https://www.thebodypro.com/category/hiv-treatments-in-development
HIV Treatment Strategies

HIV Treatments in Development

The Latest

More People With HIV Virally Suppressed on Doravirine Than Darunavir at 96 Weeks, Study Shows Img

More People With HIV Virally Suppressed on Doravirine Than Darunavir at 96 Weeks, Study Shows

After 96 weeks, more people achieved viral suppression on a doravirine-based antiretroviral drug regimen compared with a darunavir (Prezista)-based one, according to data presented at the recent 22nd International AIDS Conference.

Sex and the HIV Reservoir: New Research Points to the Powerful Effect of Estrogen Img
Women

Sex and the HIV Reservoir: New Research Points to the Powerful Effect of Estrogen

A newly published study suggests that women may respond differently than men to some HIV curative interventions that are currently under investigation or, perhaps, that an effective HIV cure for women could differ from a cure for men.

Anthony Fauci, M.D.

Anthony Fauci Discusses Research Approaches to Sustaining HIV Remission Without Antiretroviral Therapy

Fauci spoke to TheBodyPRO at this year's International AIDS Conference on approaches to HIV remission and durable control of HIV without antiretroviral therapy.

Anton Pozniak at the 90-90-90 Targets Workshop
News

How Will Long-Acting HIV Antiretrovirals Work in the Real World?

Once viable long-acting HIV prevention and treatment options have reached the market, what will be their true impact? Leading HIV clinician-researcher Anton Pozniak, M.D., shares his expertise.

Approaches to an HIV Cure Img
Reference

Approaches to an HIV Cure

Why do we lack a cure for HIV infection, and what research is underway to help achieve that goal? A new video from NIAID provides answers.

Katherine Bar, M.D.; Jonathan Li, M.D.; Davey Smith, M.D., M.A.S.
Viewpoints

Strategies for a Cure

Three researchers talk about ongoing HIV cure research within the AIDS Clinical Trials Group, treatment interruptions, and when we might see a cure.

China Approves Albuvirtide: A Once-Weekly Injectable Entry Inhibitor Img
China

China Approves Albuvirtide: A Once-Weekly Injectable Entry Inhibitor

On June 6, 2018, without news from the U.S. FDA, a press release from Frontier Biotech announced the approval of a new HIV drug in China that is given by once-weekly injection.

NIH Clinical Trial to Track Outcomes of Kidney Transplantation From HIV-Positive Donors to HIV-Positive Recipients Img
News

NIH Clinical Trial to Track Outcomes of Kidney Transplantation From HIV-Positive Donors to HIV-Positive Recipients

The first large-scale clinical trial to study kidney transplantations between people with HIV has begun at clinical centers across the U.S.

The Future of HIV Therapy Img

The Future of HIV Therapy

New strategies are here, more are on the way, and the future of ART remains bright, according to W. David Hardy, M.D.

The Role of Vaccines and Cures in HIV Elimination Img

The Role of Vaccines and Cures in HIV Elimination

Even a moderately efficacious HIV vaccine could make a significant additional contribution to halting the virus. And for HIV-positive people, a true end to HIV lies not in an epidemiological calculus, but in a cure.